Poxel SA (XPAR:POXEL)
€ 0.1406 -0.0044 (-3.03%) Market Cap: 7.53 Mil Enterprise Value: 52.36 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 11/100

Half Year 2019 Poxel SA Earnings Call Transcript

Aug 26, 2019 / 06:00PM GMT
Release Date Price: €6.3 (-1.25%)
Operator

Ladies and gentlemen, welcome to the Poxel conference call. I now hand over to Jonae Barnes. Madame, please go ahead.

Jonae R. Barnes
Poxel SA - SVP of IR & Public Relations

Thank you for joining us today for Poxel's Half Year 2019 Financial Results and Corporate Update. I'm Jonae Barnes, Senior Vice President, Investor Relations and Public Relations. With me on the call is Thomas Kuhn, CEO; Anne Renevot, CFO; Noah Beerman, President of U.S. Operations and EVP of Business Development; Sébastien Bolze, Nonclinical Development; Christophe Arbet-Engels, Chief Medical Officer, EVP Late Development and Medical Affairs; and Pascale Fouqueray-Grellier, EVP Translational Medicine and Early Clinical Development.

Before we open up the call to the question-and-answer session, we will begin with a brief overview from Thomas Kuhn, CEO. Anne Renevot, our CFO, will provide a summary of the 2019 half year financial results, and then Thomas will review our half year 2019 accomplishments and significant upcoming milestones for the remainder of 2019 and 2020.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot